| |
Mathematical modeling of HDV RNA kinetics suggests high
peginterferon lambda efficacy in blocking viral production:
Insights from the LIMT-1 study
|
| |
| |
EASL 2022 June 22-26 London
E. Fabian Cardozo-Ojeda1,2, Sarah Duehren1, Saeed S. Hamid3, Yoav Lurie4, Edward Gane5, Aanat Nevo-Shor6,
David Yardeni6, Scott J. Cotler1, Ingrid Choong7, Jeffrey Glenn8, Harel Dahari1, Ohad Etzion6
1Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, United States, 2Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States, 3Aga Khan University, Karachi, Pakistan, 4Shaare Zedek, Jerusalem, Israel, 5Auckland City Hospital, Auckland, New Zealand, 6Soroka University Medical Center, Beer-Sheba, Israel, 7Eiger BioPharmaceuticals, Inc., Palo Alto, United States, 8Stanford University, Stanford, United States
|
|
| |
| |
|
|
|
